Publisher: Adis International
ISSN: 0114-9954
Source: Reactions Weekly, Vol.1, Iss.1306, 2010-01, pp. : 2-2
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Health Canada has issued a Qualifying Notice for the approval of dronabinol/cannabidiol
Inpharma, Vol. 1, Iss. 1594, 2007-01 ,pp. :
Health Canada has reminded hospitals that Anzemet [dolasetron] is contraindicated in patients aged
Reactions Weekly, Vol. 1, Iss. 1109, 2006-01 ,pp. :